Regeneron, U.S. health department partner to develop coronavirus treatment
The U.S. Department of Health and Human Services said on Tuesday it was partnering with Regeneron Pharmaceuticals Inc to develop a treatment for the coronavirus, making the drugmaker the latest to join the race to develop a therapy.
